Network origin in Charles Haines first degree
Entity | Entity type | Industry | |
---|---|---|---|
IDBiologics, Inc.
IDBiologics, Inc. BiotechnologyHealth Technology IDBiologics, Inc. engages in the development of human monoclonal antibodies for the prevention, treatment, and cure of infectious diseases. The company was founded in 2017 and is headquartered in Nashville, TN.
3
| Holding Company | Biotechnology | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Charles Haines via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
HALOZYME THERAPEUTICS, INC. | Biotechnology | Chairman | |
Seromyx Systems, Inc.
Seromyx Systems, Inc. Pharmaceuticals: MajorHealth Technology Seromyx Systems, Inc. provides insight into the immune function to discover and develop vaccines, immunotherapies, drugs, and diagnostics. The company was founded by Galit Alter in July 2019 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chairman | |
Actym Therapeutics, Inc.
Actym Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actym Therapeutics, Inc. engages in development of novel immuno-oncology therapies. The company was founded by Christopher D. Thanos and Laura Hix Glickman and is headquartered in Berkeley, CA. | Pharmaceuticals: Major | Director/Board Member | |
Meissa Vaccines, Inc.
Meissa Vaccines, Inc. BiotechnologyHealth Technology Meissa Vaccines, Inc. operates as a pharmaceutical development company. It focuses on the in-licensing and advancement of vaccines for respiratory syncytial virus. The company was founded by Marty Moore and Roderick Tang in 2014 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
Albert B. Sabin Vaccine Institute, Inc.
Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Albert B. Sabin Vaccine Institute, Inc. creates solutions to health threats. It works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the pervasive health care challenges. The company was founded in 1993 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member | |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
K2 BioVentures LLC | Corporate Officer/Principal | ||
Integrated Genetics, Inc.
Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Part of Laboratory Corp. of America Holdings, Integrated Genetics, Inc. is a pharmaceutical preparations company. The company is based in Framingham, MA. The company was founded by Robert J. Carpenter. | Pharmaceuticals: Major | Corporate Officer/Principal | |
MPEX Pharmaceuticals, Inc.
MPEX Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services MPEX Pharmaceuticals, Inc. develops and manufactures therapies for antibiotic resistance with focus on gram-negative organisms. It offers Aeroquin (MP- 376), an aerosol formulation of levofloxacin for the treatment of pulmonary infections in patients with cystic fibrosis, as well as antibiotic programs to address antibiotic resistance in gram negative organisms. The company was founded in 2001 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Institutional Venture Partners
Institutional Venture Partners Investment ManagersFinance Institutional Venture Partners (Institutional Venture Partners) is a venture capital firm founded in 1980 by Reid Dennis. The firm is headquartered in Menlo Park, California. | Investment Managers | Corporate Officer/Principal | |
Latterell Venture Partners
Latterell Venture Partners Investment ManagersFinance Latterell Venture Partners (Latterell Venture Partners) is a venture capital firm founded in 2001 by Pat Latterell. The firm is headquartered in San Ramon, California. | Investment Managers | Corporate Officer/Principal | |
Emergent Travel Health, Inc.
Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Internet Software/Services | Chief Executive Officer | |
Fluxion Biosciences, Inc.
Fluxion Biosciences, Inc. Information Technology ServicesTechnology Services Fluxion Biosciences, Inc. conducts clinical research for early cancer detection and patient monitoring. It offers live cell analysis, automated patch clamping, and circulating tumor cell analysis. The company was founded by Michelle Khine, Cristian Ionescu-Zanetti, and Michael Schwartz in 2006 and is headquartered in Alameda, CA. | Information Technology Services | Chairman | |
Stanford University | College/University | Masters Business Admin | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
Selva Therapeutics, Inc.
Selva Therapeutics, Inc. BiotechnologyHealth Technology Selva Therapeutics, Inc. is a privately held biotechnology company based in San Mateo, CA. Selva Therapeutics is focused on rapidly developing slv213 for COVID-19 and aims to bring a valuable treatment to the market that has the potential to fight multiple life-threatening infectious diseases. Selva Therapeutics, Inc. was founded by Felix Wilhelm Frueh and Thomas E. Daley. The CEO is Thomas E. Daley. | Biotechnology | Chairman |
Statistics
International
United States | 18 |
United Kingdom | 2 |
Sectoral
Health Technology | 8 |
Commercial Services | 4 |
Finance | 3 |
Technology Services | 3 |
Consumer Services | 3 |
Operational
Director/Board Member | 10 |
Chairman | 7 |
Corporate Officer/Principal | 5 |
Chief Executive Officer | 3 |
Founder | 3 |
Most connected contacts
Insiders | |
---|---|
Kenneth Kelley | 19 |
James E. Crowe | 1 |
Mike LaBarre | 1 |
- Stock Market
- Insiders
- Charles Haines
- Company connections